DANCAN — Dancann Pharma A/S Cashflow Statement
0.000.00%
Last trade - 00:00- DKK3.97m
- DKK1.96m
- DKK6.07m
Annual cashflow statement for Dancann Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | PRESS |
| Standards: | DAS | DAS | DAS | DAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.5 | -4.25 | -11.8 | -15.9 | -11.6 |
| Non-Cash Items | 0.008 | 0.094 | 1.14 | 6.28 | 1.53 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.236 | -3.5 | -1.37 | -5.61 | 0.703 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.256 | -7.66 | -12 | -15.2 | -9.4 |
| Capital Expenditures | -1.01 | -18.8 | -32.4 | -8.36 | -4.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.322 | 0.155 | 0.34 | 0 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.01 | -19.1 | -32.2 | -8.02 | -4.4 |
| Financing Cash Flow Items | 0 | -4.67 | -0.668 | -4.67 | -0.84 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.46 | 47.9 | 30.6 | 24.1 | 5.05 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.19 | 21.1 | -13.6 | 0.857 | -8.75 |